NCT00746824View on ClinicalTrials.gov

A Study to Determine the Effects of TM30339 on Weight Loss in Obese Individuals.

PHASE2TerminatedINTERVENTIONAL

Enrollment

192

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

March 31, 2009

Conditions

Obesity

Interventions

DRUG

TM30339 and/or placebo

The drug and/or placebo will be injected in the abdominal area (site to vary for each injection). Injections will be administered twice daily for 28 days.